70.53
price down icon0.08%   -0.06
after-market After Hours: 70.53
loading
Insmed Inc stock is traded at $70.53, with a volume of 332.68K. It is down -0.08% in the last 24 hours and down -3.58% over the past month. Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension.
See More
Previous Close:
$70.59
Open:
$70.79
24h Volume:
332.68K
Relative Volume:
0.23
Market Cap:
$12.62B
Revenue:
$342.96M
Net Income/Loss:
$-864.29M
P/E Ratio:
-13.38
EPS:
-5.27
Net Cash Flow:
$-636.03M
1W Performance:
-4.50%
1M Performance:
-3.58%
6M Performance:
+3.07%
1Y Performance:
+134.79%
1-Day Range:
Value
$69.81
$70.82
1-Week Range:
Value
$68.67
$74.49
52-Week Range:
Value
$21.92
$80.53

Insmed Inc Stock (INSM) Company Profile

Name
Name
Insmed Inc
Name
Phone
908-977-9900
Name
Address
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Name
Employee
912
Name
Twitter
@insmed
Name
Next Earnings Date
2024-10-31
Name
Latest SEC Filings
Name
INSM's Discussions on Twitter

Compare INSM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
INSM
Insmed Inc
70.53 12.62B 342.96M -864.29M -636.03M -5.55
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
408.18 105.12B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
714.47 78.51B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
629.99 37.67B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
243.25 31.37B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
114.13 27.36B 3.30B -501.07M 1.03B -2.1146

Insmed Inc Stock (INSM) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-23-24 Initiated Truist Buy
Feb-15-24 Initiated Wolfe Research Outperform
Dec-08-23 Initiated Wells Fargo Overweight
Nov-20-23 Resumed JP Morgan Overweight
Jul-26-23 Initiated Guggenheim Buy
Dec-09-22 Initiated Mizuho Buy
Dec-07-22 Initiated Barclays Overweight
Nov-18-22 Initiated BofA Securities Buy
Apr-27-22 Initiated Goldman Buy
Dec-06-21 Initiated JP Morgan Overweight
Oct-19-21 Resumed Monness Crespi & Hardt Buy
Oct-19-21 Resumed Morgan Stanley Overweight
Oct-08-21 Initiated Cantor Fitzgerald Overweight
Apr-26-21 Resumed Credit Suisse Outperform
Dec-17-20 Initiated Berenberg Buy
Oct-12-20 Resumed Stifel Buy
Sep-03-19 Initiated Goldman Buy
Apr-09-19 Reiterated H.C. Wainwright Buy
Feb-15-19 Upgrade JMP Securities Mkt Perform → Mkt Outperform
Jan-17-19 Upgrade Goldman Neutral → Buy
Jan-02-19 Initiated Canaccord Genuity Buy
Aug-06-18 Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jul-23-18 Initiated Goldman Neutral
Apr-23-18 Upgrade Credit Suisse Neutral → Outperform
Mar-21-18 Initiated Morgan Stanley Overweight
Jan-18-18 Initiated Credit Suisse Neutral
Sep-05-17 Reiterated Evercore ISI Outperform
Aug-17-17 Initiated Evercore ISI Outperform
Jul-11-17 Initiated Robert W. Baird Outperform
Mar-15-16 Initiated Stifel Buy
Nov-09-15 Downgrade UBS Buy → Neutral
Oct-06-15 Reiterated H.C. Wainwright Buy
Jun-09-15 Initiated Citigroup Neutral
Mar-26-14 Reiterated HC Wainwright Buy
View All

Insmed Inc Stock (INSM) Latest News

pulisher
Dec 23, 2024

10 Best Performing Biotech Stocks in 2024 - Insider Monkey

Dec 23, 2024
pulisher
Dec 23, 2024

Is Insmed Incorporated (INSM) the Best Performing Biotech Stock in 2024? - Yahoo Finance

Dec 23, 2024
pulisher
Dec 21, 2024

Principal Financial Group Inc. Acquires 214,130 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Dec 21, 2024
pulisher
Dec 20, 2024

Insider Selling: Insmed Incorporated (NASDAQ:INSM) CEO Sells 18,750 Shares of Stock - MarketBeat

Dec 20, 2024
pulisher
Dec 20, 2024

Insmed CEO William Lewis sells $1.79 million in stock By Investing.com - Investing.com South Africa

Dec 20, 2024
pulisher
Dec 20, 2024

Insmed CEO William Lewis sells $1.79 million in stock - Investing.com

Dec 20, 2024
pulisher
Dec 18, 2024

Insmed's SWOT analysis: biopharmaceutical firm's stock poised for growth amid challenges - Investing.com

Dec 18, 2024
pulisher
Dec 18, 2024

Tidal Investments LLC Buys 19,696 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Dec 18, 2024
pulisher
Dec 15, 2024

Geode Capital Management LLC Purchases 172,664 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Dec 15, 2024
pulisher
Dec 14, 2024

Insmed CEO William Lewis sells $1.87 million in stock - Investing.com India

Dec 14, 2024
pulisher
Dec 14, 2024

Insmed CEO William Lewis sells $1.87 million in stock By Investing.com - Investing.com Australia

Dec 14, 2024
pulisher
Dec 13, 2024

Pulmonary Arterial Hypertension Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Novartis, Insmed Inc, Chugai Pharma, Merck Sharp & Dohme, Janssen Pharma, Aerovate - The Globe and Mail

Dec 13, 2024
pulisher
Dec 13, 2024

Analysts Set Insmed Incorporated (NASDAQ:INSM) PT at $83.67 - MarketBeat

Dec 13, 2024
pulisher
Dec 13, 2024

Insmed Incorporated (NASDAQ:INSM) Position Increased by Orion Portfolio Solutions LLC - MarketBeat

Dec 13, 2024
pulisher
Dec 12, 2024

Insmed's SWOT analysis: rare disease biotech stock poised for growth By Investing.com - Investing.com Canada

Dec 12, 2024
pulisher
Dec 12, 2024

Insmed's SWOT analysis: rare disease biotech stock poised for growth - Investing.com

Dec 12, 2024
pulisher
Dec 11, 2024

Wellington Management Group LLP Purchases 24,025 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Dec 11, 2024
pulisher
Dec 09, 2024

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Citizentribune

Dec 09, 2024
pulisher
Dec 09, 2024

Should You Invest in Insmed Incorporated (INSM)? - Insider Monkey

Dec 09, 2024
pulisher
Dec 08, 2024

Insmed Incorporated (NASDAQ:INSM) Shares Acquired by Castleark Management LLC - MarketBeat

Dec 08, 2024
pulisher
Dec 08, 2024

Two Sigma Advisers LP Purchases 97,300 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Dec 08, 2024
pulisher
Dec 06, 2024

Insmed To Present at December 2024 Investor Conferences - Citizentribune

Dec 06, 2024
pulisher
Dec 06, 2024

Soros Fund Management LLC Buys 7,901 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Dec 06, 2024
pulisher
Dec 06, 2024

Point72 Asset Management L.P. Sells 5,552,949 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Dec 06, 2024
pulisher
Dec 05, 2024

Insmed (LTS:0JAV) Price-to-Operating-Cash-Flow : (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024
pulisher
Dec 05, 2024

Readystate Asset Management LP Reduces Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Dec 05, 2024
pulisher
Dec 05, 2024

RTW Investments LP Decreases Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Dec 05, 2024
pulisher
Dec 05, 2024

Insmed Incorporated (NASDAQ:INSM) Shares Purchased by Polar Asset Management Partners Inc. - MarketBeat

Dec 05, 2024
pulisher
Dec 05, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Stock Holdings in Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Dec 05, 2024
pulisher
Dec 05, 2024

INSM (Insmed) Price-to-Operating-Cash-Flow : (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024
pulisher
Dec 04, 2024

Parkman Healthcare Partners LLC Has $2.59 Million Stock Holdings in Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Dec 04, 2024
pulisher
Dec 04, 2024

Patient Square Capital LP Makes New $12.53 Million Investment in Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Dec 04, 2024
pulisher
Dec 04, 2024

Bamco Inc. NY Takes Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Dec 04, 2024
pulisher
Dec 04, 2024

Cerity Partners LLC Buys 17,869 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Dec 04, 2024
pulisher
Dec 03, 2024

Insmed Incorporated (NASDAQ:INSM) Stake Reduced by HighVista Strategies LLC - MarketBeat

Dec 03, 2024
pulisher
Dec 03, 2024

Cinctive Capital Management LP Sells 114,851 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Dec 03, 2024
pulisher
Dec 03, 2024

Erste Asset Management GmbH Buys New Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Dec 03, 2024
pulisher
Dec 02, 2024

Why Is Insmed Incorporated (INSM) Among the Best High Growth Healthcare Stocks to Invest In Now? - Insider Monkey

Dec 02, 2024
pulisher
Dec 02, 2024

Insmed to Present at Evercore ISI HealthCONx and Nasdaq Investor Conferences - StockTitan

Dec 02, 2024
pulisher
Dec 01, 2024

Bellevue Group AG Reduces Holdings in Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Dec 01, 2024
pulisher
Nov 30, 2024

Insmed (LTS:0JAV) Forward Dividend Yield % : 0.00% (As of Nov. 30, 2024) - GuruFocus.com

Nov 30, 2024
pulisher
Nov 30, 2024

Eventide Asset Management LLC Grows Stock Holdings in Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Nov 30, 2024
pulisher
Nov 29, 2024

Vestal Point Capital LP Purchases 850,000 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Nov 29, 2024
pulisher
Nov 29, 2024

Insmed Incorporated (NASDAQ:INSM) is Suvretta Capital Management LLC's 3rd Largest Position - MarketBeat

Nov 29, 2024
pulisher
Nov 28, 2024

Groundbreaking Insights Unveiled in Non-Cystic Fibrosis Bronchiectasis Pipeline Report - GlobeNewswire Inc.

Nov 28, 2024
pulisher
Nov 28, 2024

Insmed Incorporated (NASDAQ:INSM) Shares Bought by Ally Bridge Group NY LLC - MarketBeat

Nov 28, 2024
pulisher
Nov 28, 2024

Insmed Incorporated (NASDAQ:INSM) is Acuta Capital Partners LLC's 4th Largest Position - MarketBeat

Nov 28, 2024
pulisher
Nov 27, 2024

Insmed Insiders Sold US$3.8m Of Shares Suggesting Hesitancy - Simply Wall St

Nov 27, 2024
pulisher
Nov 27, 2024

Charles Schwab Investment Management Inc. Raises Stake in Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Nov 27, 2024
pulisher
Nov 26, 2024

Qsemble Capital Management LP Takes $1.69 Million Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Nov 26, 2024
pulisher
Nov 26, 2024

Natixis Advisors LLC Makes New $1.53 Million Investment in Insmed Incorporated (NASDAQ:INSM) - MarketBeat

Nov 26, 2024

Insmed Inc Stock (INSM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$69.91
price up icon 0.10%
$19.00
price up icon 1.77%
$40.27
price up icon 1.72%
$360.87
price down icon 0.76%
$181.62
price up icon 2.21%
$114.13
price up icon 0.55%
Cap:     |  Volume (24h):